M. C. CarreÇo, A. Urbano et al.
7.7 Hz, 1H), 7.23 (d, J=7.7 Hz, 1H), 7.29 (t, J=7.7 Hz, 1H), 7.58,
7.95 ppm (AB system, J=7.7 Hz, 2H); 13C NMR: d=20.4, 26.9, 29.7,
30.8, 30.9, 123.8, 124.7, 125.1, 128.5, 131.0, 131.3, 131.6, 134.5, 137.4,
139.9, 146.2, 149.2, 184.9, 185.3 ppm;MS (EI): m/z (%): 202 (9), 229 (11),
259 (100), 302 [M]+ (3);MS (EI): m/z: calcd for C21H18O2: 302.13068;
found: 302.13097;elemental analysis calcd (%) for C 21H18O2: C 83.42, H
6.00;found: C 83.12, H 6.50;HPLC (Daicel Chiralpack OD chiral
column, hexane/2-propanol 90:10): 0.5 mLminꢀ1, 254 nm, Rt =20.3 min,
T=258C, 80% ee.
(P)-12-tert-Butyl-6-ethoxy-7,8-dihydrobenzo[c]phenanthrene-1,4-dione
(5d): Compound (P)-5d was obtained from diene 7d by following gener-
al procedure E (2 equiv of (SS)-8, ꢀ208C, 3 d, eluent: EtOAc/hexane
1:20) in 57% yield as an orange solid. M.p.: 118–1208C (CH3CN);[ a]D20
=
+977 (c=0.03 in CHCl3); 1H NMR: d=1.06 (s, 9H), 1.52 (t, J=7.1 Hz,
3H), 2.11 (dt, J=4.5, 14.7 Hz, 1H), 2.47 (dt, J=4.4, 14.7 Hz, 1H), 2.73
(ddd, J=2.2, 4.2, 15.1 Hz, 1H), 3.30 (ddd, J=2.2, 3.6, 14.7 Hz, 1H), 4.25
(dq, J=20.0, 7.1 Hz, 2H), 6.68, 6.81 (AB system, J=10.1 Hz, 2H), 7.14
(d, J=7.1 Hz, 1H), 7.25 (t, J=7.7 Hz, 1H), 7.37 (d, J=8.0 Hz, 1H),
7.48 ppm (s, 1H); 13C NMR: d=14.7, 23.1, 31.2, 33.9, 37.5, 64.5, 106.9,
123.8, 127.0, 127.2, 129.3, 130.1, 131.7, 132.1, 136.3, 137.2, 140.1, 141.0,
149.4, 157.9, 184.0, 185.6 ppm;MS (EI): m/z (%): 71 (10), 85 (6), 189
(12), 229 (6), 247 (10), 275 (55), 303 (100), 362 ppm (4) [M+2]+;MS
(EI): m/z: calcd for C24H24O3: 360.17254;found: 360.17126;HPLC
(Daicel Chiralcel OD chiral column, hexane/2-propanol 90:10):
0.5 mLminꢀ1, 254 nm, Rt =14.0 min, T=258C, 95% ee.
Method B: Compound (P)-4c was obtained from diene 6c by following
general procedure F (13 h, eluent: CH2Cl2/hexane 4:1) in 73% yield as
an orange solid. [a]2D0 =+1758 (c=0.05 in CHCl3);HPLC: (Daicel Chir-
alpack OD chiral column, hexane/2-propanol 90/10): 0.5 mLminꢀ1
,
254 nm, Rt =20.9 min, T=258C, 82% ee.
(P)-12-Isopropyl-6-ethoxy-7,8-dihydrobenzo[c]phenanthrene-1,4-dione
(5c): Compound (P)-5c was obtained from diene 7c by following general
procedure E (2 equiv of (SS)-8, ꢀ208C, 3 h, eluent: EtOAc/hexane 1:40)
Helicene biscamphanate (M)-19b: Compound (M)-19b was obtained
from 7,8-dihydro[4]helicene quinone (P,M)-4b by following general pro-
cedure G, after chromatographic separation (eluent: EtOAc/hexane 1:2)
of the mixture with helicene biscamphanate (P)-19b, in 40% yield as a
yellowish oil. Rf =0.53 (EtOAc/hexane 1:2);[ a]2D0 =ꢀ186 (c=0.09 in
CHCl3); 1H NMR: d=0.79 (s, 3H), 0.94 (s, 3H), 1.03 (s, 3H), 1.20 (s,
3H), 1.21 (s, 3H), 1.22 (s, 3H), 1.37–1.51 (m, 1H), 1.56–1.73 (m, 2H),
1.77–1.88 (m, 1H), 1.94 (s, 3H), 1.98–2.13 (m, 1H), 2.27–2.40 (m, 1H),
2.61–2.88 (m, 6H), 7.10 (dd, J=7.3, 1.4 Hz, 1H), 7.14 (t, J=7.3 Hz, 1H),
7.19 (dd, J=7.3, 1.4 Hz, 1H), 7.30, 7.15 (AB system, J=8.1 Hz, 2H),
7.45, 7.35 ppm (AB system, J=8.3 Hz, 2H);MS (EI): m/z (%): 83 (66),
125 (14), 259 (29), 456 (11), 636 (100) [M]+;MS (EI): m/z: calcd for
C39H40O8: 636.27232;found: 636.27155.
in 65% yield as an orange solid. M.p.: 178–1808C (CH3CN);[ a]D20
=
1
+1678 (c=0.08 in CHCl3); H NMR: d=0.74 (d, J=6.7 Hz, 3H), 1.24 (d,
J=6.7 Hz, 3H), 1.51 (t, J=7.1 Hz, 3H), 2.09 (dt, J=15.6, 4.5 Hz, 1H),
2.59 (dt, J=14.5, 3.8 Hz, 1H), 2.77 (ddd, J=14.5, 4.5, 2.4 Hz, 1H), 3.21
(sept, J=6.7 Hz, 1H), 3.32 (ddd, J=15.6, 3.8, 2.4 Hz, 1H), 4.14–4.36 (dq,
J=9.2, 7.1 Hz, 2H), 6.80, 6.88 (AB system, J=10.2 Hz, 2H), 7.15 (d, J=
7.5 Hz, 1H), 7.20 (d, J=7.5 Hz, 1H), 7.27 (t, J=7.5 Hz, 1H), 7.48 ppm (s,
1H); 13C NMR: d=14.7, 20.6, 22.6, 26.9, 29.7, 30.5, 64.5, 106.5, 123.5,
124.5, 125.0, 128.3, 131.3, 132.2, 136.7, 136.8, 137.7, 139.8, 140.2, 146.4,
158.9, 184.2, 185.4 ppm;MS (FAB +): m/z (%): 283 (48), 303 (17), 327
(93), 347 (11) [M+1]+;MS (FAB +): m/z: calcd for C23H23O3: 347.16472;
found: 347.16318;elemental analysis calcd (%) for C 23H22O3 (346.2): C
79.39, H 6.46;found: C 79.74, H 6.40;HPLC (Daicel Chiralpack OD
Helicene biscamphanate (P)-19b: Compound (P)-19b was obtained from
7,8-dihydro[4]helicene quinone (P,M)-4b as above, in 45% yield, or from
(P)-4b by following general procedure G (eluent: EtOAc/hexane 1:2), in
82% yield, as a white solid. Rf =0.43 (EtOAc/hexane 1:2);m.p. 266–
2688C (CH3CN);[ a]2D0 =+222 (c=0.1 in CHCl3); 1H NMR: d=0.84 (s,
3H), 1.04 (s, 3H), 1.09 (s, 3H), 1.20 (s, 3H), 1.21 (s, 3H), 1.22 (s, 3H),
1.50–1.62 (m, 2H), 1.70–1.80 (m, 1H), 1.85–1.90 (m, 1H), 1.87 (s, 3H),
2.07–2.13 (m, 1H), 2.32–2.42 (m, 1H), 2.65–2.90 (m, 6H), 7.30, 7.15 (AB
system, J=8.5 Hz, 2H), 7.15 (dd, J=7.4, 3.9 Hz, 1H), 7.20 (dd, J=7.4,
3.9 Hz, 1H), 7.21 (t, J=7.4, 1H), 7.85, 7.65 ppm (AB system, J=8.0 Hz,
2H);MS (EI): m/z (%): 83 (63), 125 (12), 259 (24), 456 (10), 636 (100)
[M]+;MS (EI): m/z: calcd for C39H40O8: 636.27232;found: 636.27460.
chiral column, hexane/2-propanol 95:5): 0.5 mLminꢀ1
, 254 nm, Rt =
52.7 min, T=258C, 97% ee.
A
dione (17d): Compound (12bR,M)-17d was obtained from diene 6d by
following general procedure E (2 equiv of (SS)-8, 208C, 7 d, eluent:
EtOAc/hexane 1:12), after separation of the 25:15:60 mixture of 17d, 4d
and 18, in 14% yield as a red solid. M.p.: 188–1898C (CH3CN);[ a]D20
=
ꢀ240 (c=0.02 in CHCl3); 1H NMR: d=1.32 (s, 9H), 2.24 (m, 1H), 2.41
(dt, J=13.9, 3.1 Hz, 1H), 2.51 (ddd, J=4.2, 9.5, 18.8 Hz, 1H), 2.64 (dt,
J=3.0, 13.2 Hz, 1H), 3.75 (dt, J=3.2, 14.3 Hz, 1H), 3.81 (ddd, J=1.3,
6.6, 18.8 Hz, 1H), 4.63 (d, J=8.8 Hz, 1H), 5.91 (dq, J=6.6, 2.0 Hz, 1H),
6.37, 6.61 (AB system, J=7.3 Hz, 2H), 7.06 (d, J=7.3 Hz, 1H), 7.23 (d,
J=7.4 Hz, 1H), 7.36 ppm (dt, J=1.1, 8.1 Hz, 1H); 13C NMR: d=25.4,
31.4, 31.8, 32.1, 36.0, 42.8, 119.0, 124.8, 126.3, 133.1, 134.5, 137.0, 141.9,
145.8 (2C), 146.4, 147.3, 147.7, 184.9, 185.6 ppm;MS (EI): m/z (%): 57
(100), 115 (6), 189 (8), 202 (12), 233 (9), 245 (6), 262 (73), 320 (16)
[M+2]+;MS (EI): m/z: calcd for C22H22O2: 318.16198;found: 318.16116;
HPLC (Daicel Chiralpack AS chiral column, hexane/2-propanol 97:3),
0.7 mLminꢀ1, 254 nm, Rt =8.4 min, T=258C, 72% ee.
Helicene biscamphanate (M)-20d: Compound (M)-20d was obtained
from 7,8-dihydro[4]helicene quinone (P,M)-5d by following general pro-
cedure G, after chromatographic separation (eluent: EtOAc/hexane 1:2)
of the mixture with helicene biscamphanate (P)-20d, in 42% yield as a
yellowish oil. Rf =0.42 (EtOAc/hexane 1:2);[ a]2D0 =ꢀ116 (c=0.12 in
CHCl3); 1H NMR (500 MHz): d=0.81 (s, 3H), 0.87 (s, 9H), 0.97, 1.07,
1.22, 1.23, 1.24 (5s, 53H), 1.41 (m, 1H), 1.54 (t, J=7.0 Hz, 3H), 1.55,
1.73, 1.85, 1.87, 2.08, 2.19 (6 m, 6H), 2.34 (dt, J=4.5, 9.0 Hz, 1H), 2.46
(m, 1H), 2.70 (m, 2H), 3.30 (ddd, J=2.0, 4.0, 16.0 Hz, 1H), 4.14–4.24 (m,
2H), 6.79, 7.24 (AB system, J=8.2 Hz, 2H), 7.03 (d, J=7.2 Hz, 1H), 7.19
(t, J=7.1 Hz, 1H), 7.21 (s, 1H), 7.52 ppm (ddd, J=0.6, 1.3, 8.0 Hz, 1H);
MS (EI): m/z (%): 55 (21), 83 (61), 97 (20), 125 (13), 137 (14), 275 (19),
303 (35), 484 (14), 722 (100) [M]+;MS (EI): m/z: calcd for C44H50O9:
722.34548;found: 722.34772.
(P)-12-tert-Butyl-7,8-dihydrobenzo[c]phenanthrene-1,4-dione (4d)
Method A: Compound (P)-4d was obtained from diene 6d by following
general procedure E (2 equiv of (SS)-8, 208C, 7 d, eluent: EtOAc/hexane
1:12), after separation of the 25:15:60 mixture of 17d, 4d and 18, in 10%
yield as a red solid. M.p.: 172–1748C (CH3CN);[ a]2D0 =+1371 (c=0.02 in
CHCl3); 1H NMR: d=1.32 (s, 9H), 2.57, 2.79 (2 m, 4H), 6.77, 6.91 (AB
system, J=10.3 Hz, 2H), 7.16 (d, J=7.5 Hz, 1H), 7.27 (t, J=7.1 Hz, 1H),
7.57 (d, J=7.8 Hz, 1H), 7.57, 7.98 (AB system, J=7.9 Hz, 2H);MS (EI):
m/z (%): 55 (35), 57 (66), 69 (36), 71 (27), 83 (19), 121 (16), 149 (39), 202
(13), 229 (35), 260 (78), 316 (100) [M]+;MS (EI): m/z: calcd for
C22H20O2: 316.14663;found: 316.14612;HPLC (Daicel Chiralpack AS
Helicene biscamphanate (P)-20d: Compound (P)-20d was obtained from
7,8-dihydro[4]helicene quinone (P,M)-5d as above, in 42% yield, or from
(P)-5d by following general procedure G (eluent: EtOAc/hexane 1:2) in
78% yield as a yellowish oil. Rf =0.34 (EtOAc/hexane 1:2);[ a]2D0 =+92
(c=0.16 in CHCl3); 1H NMR: (500 MHz): d=0.80 (s, 3H), 0.81 (s, 9H),
1.05 (s, 3H), 1.08 (s, 3H), 1.23 (s, 6H), 1.24 (s, 3H), 1.51 (t, J=7.0 Hz,
3H), 1.40, 1.56, 1.79, 1.85, 1.91, 2.06, 2.14 (7 m, 7H), 2.32 (dt, J=4.5,
9.0 Hz, 1H), 2.52 (m, 1H), 2.67 (m, 2H), 3.24 (ddd, J=2.0, 4.0, 16.0 Hz,
1H), 4.12–4.24 (m, 2H), 6.75, 7.23 (AB system, J=8.2 Hz, 2H), 7.13 (d,
J=7.2 Hz, 1H), 7.18 (s, 1H), 7.18 (t, J=7.1 Hz, 1H), 7.41 ppm (dd, J=
1.3, 8.0 Hz, 1H); 13C NMR (125 MHz): d=10.0, 10.1, 15.2, 17.3, 17.3,
17.5, 24.0, 29.4 (2C), 29.5, 30.1, 31.6, 32.2, 32.9, 37.5, 54.9, 55.0, 55.4, 64.3,
91.1, 91.5, 98.8, 115.6, 116.8, 123.9, 125.9, 126.9, 127.9, 128.2, 134.0, 134.6,
chiral column, hexane/2-propanol 99:1): 0.3 mLminꢀ1
, 254 nm; Rt =
29.5 min, T=258C, 72% ee.
Method B: Compound (P)-4d was obtained from diene 6d by following
general procedure F (24 h, eluent: EtOAc/hexane 1:4), after separation
of the 40:60 mixture of 4d and 18, in 37% yield as a red solid. [a]D20
=
+1573 (c=0.1 in CHCl3);HPLC: (Daicel Chiralpack OD chiral column,
hexane/2-propanol 99:1): 0.5 mLminꢀ1, 254 nm; Rt =20.9 min, T=258C,
80% ee.
618
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2008, 14, 603 – 620